| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 01/05/2005 | CN1183098C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 01/04/2005 | US6838584 Estrogen receptor modulators |
| 01/04/2005 | US6838565 Factor x inhibitor; anticoagulants |
| 01/04/2005 | US6838561 2-substituted-4-amino-phenol derivative compounds providing good oxidative coloration of hair and acceptable light fastness, fastness to shampooing and permanent wave treatment |
| 01/04/2005 | US6838470 Antiischemic agents; brain disorders; cardiovascular disorders |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 01/04/2005 | US6838461 Psychological disorders; schizophrenia; Alzheimer's disease; Parkinson's disease; Huntington's disease; cardiovascular disorders; hypotensive agents; side effect reduction |
| 01/04/2005 | US6838460 Substituted phenylamidines medicaments containing said compounds and method for production thereof |
| 01/04/2005 | CA2148827C Novel 3,3-diphenylpropylamines, their use and preparation |
| 01/04/2005 | CA2147155C Amide derivatives |
| 12/30/2004 | US20040266870 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents |
| 12/30/2004 | US20040266855 Effective against Src family; cancer, osteoporosis |
| 12/30/2004 | US20040266787 Novel amorphous form of [2-[4-[(4-chlorophenyl)-phenyl methyl]-1-piperazinyl]ethoxy]acetic acid and process for the preparation thereof |
| 12/30/2004 | US20040266786 1-(2 chlorophenyl-1-piperazinyl)-2-propanol-3-oxy-(2-methoxy-propenyl)-benzene; alpha 2-adrenergic/5-HT2A antagonist, 5-HT re-uptake inhibition, and anti-oxidant activities |
| 12/30/2004 | US20040266785 KMST isoeugenol derivatives and pharmaceutical activity |
| 12/30/2004 | US20040266784 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 12/30/2004 | US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 12/29/2004 | WO2004113391A2 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 12/29/2004 | WO2004113312A1 Hydroxamate sulfonamides as cd23 shedding inhibitors |
| 12/29/2004 | WO2004113311A1 Amorphous und crystal forms of (5-chloro-2-{2- |
| 12/29/2004 | WO2004113277A2 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | WO2004113275A2 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | WO2004113270A2 Propionic acid derivatives useful in the treatment of lipid disorders |
| 12/29/2004 | WO2004112787A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 12/29/2004 | WO2004086050A3 Labelling agents for mass spectrometry comprising tertiary amines |
| 12/29/2004 | WO2004002940A8 Inhibitors of hcv ns5b polymerase |
| 12/29/2004 | WO2002043648A3 Compounds active at the glucocorticoid receptor ii |
| 12/29/2004 | EP1491187A1 Preventive or therapeutic agent for kidney disease |
| 12/29/2004 | EP1490346A2 Stereoselective alkylation of chiral 2-methyl-4-protected piperazines |
| 12/29/2004 | EP1490338A1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases |
| 12/29/2004 | EP1490054A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 12/29/2004 | EP1265891B1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 12/29/2004 | EP1171419B1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor |
| 12/29/2004 | EP1163209A4 Compounds and compositions for delivering active agents |
| 12/29/2004 | EP1102538B1 Plant growth regulator compositions |
| 12/29/2004 | CN1557811A Phenoxy indenone compounds ,process for preparing same and use thereof |
| 12/29/2004 | CN1182109C ((Aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy |
| 12/29/2004 | CN1181817C NF-KB inhibitors containing phenylmethyl benzoquinone as active ingredient |
| 12/29/2004 | CA2529257A1 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | CA2529256A1 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | CA2528538A1 Dual function compounds and uses thereof |
| 12/29/2004 | CA2528317A1 Hydroxamate sulfonamides as cd23 shedding inhibitors |
| 12/29/2004 | CA2528234A1 Propionic acid derivatives useful in the treatment of lipid disorders |
| 12/28/2004 | US6835839 Method for the production of biperiden II |
| 12/28/2004 | US6835832 Catalytic hydrogenation |
| 12/28/2004 | US6835831 Efficient synthesis of ceramide-like compounds by reacting an aldehyde and an amidomethylisonitrile to form a 4-amido-2-oxazoline; suppress biosynthesis of glycosphingolipids; antitumor agents; Tays-Sach, Gaucher's |
| 12/28/2004 | US6835734 1,3-dioxolanes with antitussive activity |
| 12/23/2004 | WO2004111025A1 Para-substituted phenyl carbamates as inhibitors of hormone sensitive lipase |
| 12/23/2004 | WO2004110989A1 N-hydroxy-7-(arylamino)heptanamide derivatives useful for treating hyper-proliferative disorders |
| 12/23/2004 | WO2004110986A1 Benzamide derivative or salt thereof |
| 12/23/2004 | WO2004110978A2 1-aminonaphthalenes as modulators of androgen, glucocorticoid, mineralocorticoid and progesterone receptors |
| 12/23/2004 | WO2004110418A2 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease |
| 12/23/2004 | WO2004110389A2 Sigma ligands for neuronal regeneration and functional recovery |
| 12/23/2004 | WO2004110388A2 Sigma ligands for neuronal regeneration and functional recovery |
| 12/23/2004 | WO2004110387A2 Sigma ligands for neuronal regeneration and functional recovery |
| 12/23/2004 | WO2004110364A2 Thiotungstate analogues and uses thereof |
| 12/23/2004 | WO2004099150A3 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 12/23/2004 | WO2003104211A3 Crystalline [2-[4-[(4-chlorophenyl)-phenyl methyl]-1-piperazinyl] ethoxy] acetic acid dihydrochloride |
| 12/23/2004 | US20040260100 Sulfonylation of N-protected prolinol, hydrogenation with an alkali triethylboron hydride; N-protected-2-iodomethylpyrrolidine is formed by reacting the sulfonate with an alkali iodide salt; histamine-3 receptor modulator precursors |
| 12/23/2004 | US20040260099 D-t-3',4'-ethylenedioxy-p4 derivatives; glucosyl ceramide inhibitors lower glycosphingolipid levels; anticarcinogenic, antitumor agents; angiogenesis inhibitors; tumor antigens |
| 12/23/2004 | US20040260089 reacting diphosphorus pentoxide, an organic base (melamine, guanidine, piperazine), and a water releasing agent (borax, aluminum or magnesium hydroxide, or oxalic or formic acid) to form polyphosphate salts; fire retardants for thermoplastic polyamide or polyester platics |
| 12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |
| 12/23/2004 | US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents |
| 12/23/2004 | US20040259866 Calcium channel blockers comprising two benzhydril moieties |
| 12/23/2004 | US20040259861 Antiischemic agents |
| 12/23/2004 | US20040259840 Using phosphoglycerides, lipid having sphingosine base, glycerides and sterol; wound healing agents; atherosclerosis |
| 12/23/2004 | US20040255403 Primary intermediates for oxidative coloration of hair |
| 12/23/2004 | DE10323898A1 Hydroxyamidin- und Hydroxyguanidin-Verbindungen als Urokinase-Hemmstoffe Hydroxyamidine and hydroxyguanidine compounds as inhibitors of urokinase |
| 12/23/2004 | CA2528003A1 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease |
| 12/23/2004 | CA2527236A1 Thiotungstate analogues and uses thereof |
| 12/23/2004 | CA2526387A1 Benzamide derivative or salt thereof |
| 12/22/2004 | EP1487811A1 N-sulfonylurea apoptosis promoters |
| 12/22/2004 | EP1487810A2 4-(diarylmethyl)-1-piperazinyl derivatives |
| 12/22/2004 | EP1487790A1 Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization |
| 12/22/2004 | EP1487788A1 Diaminoacid-aminoacid-polyamine based gemini surfactant compounds |
| 12/22/2004 | EP1487573A2 Catalysts and method for the production of amines |
| 12/22/2004 | EP1487449A1 Tyrosyl derivatives and their use as p2x7 receptor modulators |
| 12/22/2004 | EP1487428A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 12/22/2004 | EP1080066A4 Bioreductive cytotoxic agents |
| 12/22/2004 | EP0929536B1 Piperazine based cytofectins |
| 12/22/2004 | CN1556703A 1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1 antagonistic activity |
| 12/22/2004 | CN1181065C Aralkylformylakyl piperazine derivative and its application as brain nerve protector |
| 12/22/2004 | CN1181043C Quaternary bis-ammonium salt precursors and their uses as prodrugs having antiparasitic activity |
| 12/21/2004 | US6833384 Deacetylase inhibitors |
| 12/21/2004 | US6833382 Streptogramins and method for preparing same by mutasynthesis |
| 12/21/2004 | US6833369 Treatment of ocular neovascular diseases, neovascular glaucoma, diabetic retinopathy, |
| 12/21/2004 | CA2322989C Oxidation dyeing compositions containing a cationic coupling agent, novel cationic coupling agents |
| 12/16/2004 | WO2004108673A2 Inhibitors of papilloma virus |
| 12/16/2004 | WO2004087685A3 Phospholipase c inhibitors for use in treating inflammatory disorders |
| 12/16/2004 | WO2004052939A3 Ligands for metals and improved metal-catalyzed processes based thereon |
| 12/16/2004 | WO2004050022A8 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/16/2004 | WO2003063797A8 Cycloalkyl inhibitors of potassium channel function |
| 12/16/2004 | US20040254375 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
| 12/16/2004 | US20040254344 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 12/16/2004 | US20040254280 Blends of waxes and polymer additives |
| 12/16/2004 | US20040254196 Cinnamaldehyde derivatives inhibiting growth of tumor cell and regulating cell cycle, preparations and pharmaceutical compositions thereof |
| 12/16/2004 | US20040254165 Vitiligo; skin cancer; control skin coloring |
| 12/16/2004 | US20040254156 opioid receptor agonists such as 2-[4-(methanesulfonylamino-methyl)-phenyl]-N-methyl-N-[1-(S)-phenyl-2-pyrrolidin-1-ylethyl]-acetamide used for preventing pain, pruritus and gastrointestinal disorders |
| 12/16/2004 | US20040251452 1,3,5-Tricyano-2,4,6-tris(vinyl)benzene derivatives and method for preparing the same |
| 12/16/2004 | CA2526506A1 Inhibitors of papilloma virus |